Synthesis and biological evaluation of a monocyclic Fc-binding antibody-recruiting molecule for cancer immunotherapy
- 21 January 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 12 (3) , 406-409
Abstract
Antibody-recruiting molecules (ARMs) are bispecific molecules composed of an antibody-binding motif and a target-binding motif that redirect endogenous antibodies to target cells to elicit immune responses. To enhance the translational potential of ARMs, it is crucial to design antibody/target-binding motifs that have strong affinity and are easy to synthesize. Here, we synthesized a novel Fc-binding ARM (Fc-ARM) that targets folate receptor (FR)-positive cancer cells, Reo-3, using a recently developed monocyclic peptide 15-Lys8Leu, which binds strongly to the Fc region of an antibody. Reo-3 bound to the Fc region of the antibody with a Kd of 5.8 nM, and recruited a clinically used antibody mixture to attack FR-positive IGROV-1 cells as efficiently as Fc-ARM2, in which a bicyclic Fc-binding peptide was used. These results indicate that 15-Lys8Leu, which can be synthesized readily, is suitable for various applications including the development of Fc-ARMs.Keywords
Funding Information
- Japan Society for the Promotion of Science (17J05032)
- Japan Society for the Promotion of Science (18K19148)
- Japan Society for the Promotion of Science (19H03356)
- Kyushu University
This publication has 23 references indexed in Scilit:
- Antibody-Recruiting Molecules: An Emerging Paradigm for Engaging Immune Function in Treating Human DiseaseACS Chemical Biology, 2012
- The safety and side effects of monoclonal antibodiesNature Reviews Drug Discovery, 2010
- An Antibody-Recruiting Small Molecule That Targets HIV gp120Journal of the American Chemical Society, 2009
- Neutralization of HIV-1 by redirection of natural antibodiesProceedings of the National Academy of Sciences, 2008
- Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Protein aggregation and bioprocessingThe AAPS Journal, 2006
- Design and synthesis of αGal-conjugated peptide T20 as novel antiviral agent for HIV-immunotargetingOrganic & Biomolecular Chemistry, 2004
- Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumorsCancer Immunology, Immunotherapy, 2002
- Bacteria targeted by human natural antibodies using α-gal conjugated receptor-specific glycopolymersBioorganic & Medicinal Chemistry, 1999
- Antibody targeting to bacterial cells using receptor-specific ligandsJournal of the American Chemical Society, 1992